Navigation Links
Dysfunctional chemokine receptor promotes candidiasis
Date:11/1/2013

Candida albicans is one of the leading causes of hospital-acquired infections in immune compromised patients. The risk of both developing candidiasis and the clinical outcome of infection is variable among patients, and the host-dependent factors that contribute to patient susceptibility to C. albicans infection are poorly understood. In this issue of the Journal of Clinical Investigation, Michail Lionakis and colleagues at the National Institute of Allergy and Infectious Diseases demonstrated that the chemokine receptor CX3CR1 is required for the interaction of C. albicans and macrophages in the kidney. Mice lacking this receptor were prone to C. albicans-induced kidney failure; however, these mice did not have increased fungal burden in other organs. Furthermore, the authors found that patients with a mutation in the gene encoding CX3CR1 were at higher risk of candidiasis. This study identifies an important role for the interaction of C. albicans and macrophages in disease progression and outcome.


'/>"/>

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related biology news :

1. Has modern science become dysfunctional?
2. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
3. G protein-coupled receptor mediates the action of castor oil
4. BUSM study identifies receptors role in regulating obesity, type 2 diabetes
5. Cell receptor has proclivity for T helper 9 cells, airway inflammation
6. Steroid hormone receptor prefers working alone to shut off immune system genes
7. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
8. Dopamine-receptor gene variant linked to human longevity
9. How the tilt of a cell-surface receptor prevents cancer
10. Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
11. Therapies for ALL and AML targeting MER receptor hold promise of more effect with less side-effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... 2014GEN Publishing recently introduced Clinical OMICs ... the application of OMICs technologies in clinical settings. ... beginning to transform medical care just as they ... decade-and-a-half. , "GEN,s editors and reporters have written ... transcriptomics, etc. etc. for years," said John Sterling, ...
(Date:4/24/2014)... invented a simple and cheap way of making a ... a high-resolution microscope. , Costing less than a cent, ... in developing countries and remote areas. , The lens ... The Australian National University (ANU) Research School of Engineering, ... Institute of Medical Research to find ways to transform ...
(Date:4/24/2014)... North Carolina State University and the University of North ... device that could help identify arterial plaque that is ... attack or stroke. , At issue is the plaque ... types of plaque are deemed "vulnerable," meaning that they ... and cause heart attack or stroke. , "Existing state-of-the-art ...
Breaking Biology News(10 mins):Droplet lens 2New ultrasound device may add in detecting risk for heart attack, stroke 2
... Assistant Professor, Department of Microbiology & Immunology, University of ... with one of two 2012 Merck Irving S. Sigal ... scientists to recognize and award excellence in basic research ... memory of Irving S. Sigal, an instrumental figure in ...
... Kaye Wachsmuth, Ph.D., International Public Health Consultant, DeLand, ... Public Health Award. This award, established in honor ... who has exhibited exemplary leadership and service in ... award "for almost forty years of implementing state-of-the-art ...
... Talk about throwing yourself into a relationship too soon. A ... gets a whiff of female sex attractant, he,s quicker to start ... prematurely when he,s still too cool for powerful flight. So his ... race. The study illustrates the tradeoff between being quick to ...
Cached Biology News:The American Society for Microbiology honors Susan Sharp 2The American Society for Microbiology honors I. Kaye Wachsmuth 2The American Society for Microbiology honors I. Kaye Wachsmuth 3Virgin male moths think they're hot when they're not 2Virgin male moths think they're hot when they're not 3Virgin male moths think they're hot when they're not 4Virgin male moths think they're hot when they're not 5
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 DTS ... to its Online Web Portal for Life Science organizations who ... to specify the subject matter of their documents in advance ... will help reduce time-to-delivery of translations, often a critical factor ...
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
... SAN FRANCISCO, July 20 Burrill & Company, a San ... Private Equity, Merchant Banking and Media, is pleased to announce that ... Director, for both Burrill & Company and Burrill Latin America. ... of Rio Bravo Venture Partners, an asset management firm created from ...
... BOZEN, Italy, July 20 Health ... with Charite-Universitatsmedizin,Berlin. Charite will install an i.v.STATION robot at ... The primary challenges in today,s ... time, waste, regulatory issues,lack of audit trails, motion injuries, ...
... , BASKING RIDGE, N.J., July ... the development of antithrombotic therapeutic aptamers with active control agents, ... Three new members (Dr. John Eikelboom of Canada, Dr. ... join the original members bringing the current size of the ...
Cached Biology Technology:Joao Paulo Baptista Joins Burrill & Company 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 3Regado Biosciences Expands Medical Advisory Board 2Regado Biosciences Expands Medical Advisory Board 3Regado Biosciences Expands Medical Advisory Board 4
12 breakable polypropylene strips of 8 wells each held in a rigid frame. Ideal for antibody assays....
... in vitro diagnostic assays, all EIA/RIA plates ... uniform binding, high optical clarity and low ... part of the Certified Surface Chemistry Programme, ... within QA release specifications. Linkage: This CLS ...
... Stabilizer is an aqueous solution that contains ... stabilizing chemicals in a saline solution, pH ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ... a diluent and stabilizer for biologically active ...
AC input: 230 V...
Biology Products: